REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 191 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,612 | -72.7% | 838 | -39.8% | 0.00% | -100.0% |
Q2 2023 | $35,257 | -21.4% | 1,393 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $44,869 | +1458.0% | 1,393 | +792.9% | 0.00% | – |
Q4 2022 | $2,880 | -58.9% | 156 | -36.8% | 0.00% | – |
Q3 2022 | $7,000 | +250.0% | 247 | +126.6% | 0.00% | – |
Q2 2022 | $2,000 | 0.0% | 109 | +28.2% | 0.00% | – |
Q1 2022 | $2,000 | -66.7% | 85 | -76.4% | 0.00% | – |
Q4 2021 | $6,000 | +200.0% | 360 | +445.5% | 0.00% | – |
Q3 2021 | $2,000 | 0.0% | 66 | -18.5% | 0.00% | – |
Q2 2021 | $2,000 | 0.0% | 81 | +22.7% | 0.00% | – |
Q1 2021 | $2,000 | 0.0% | 66 | 0.0% | 0.00% | – |
Q4 2020 | $2,000 | 0.0% | 66 | 0.0% | 0.00% | – |
Q3 2020 | $2,000 | 0.0% | 66 | 0.0% | 0.00% | – |
Q2 2020 | $2,000 | +100.0% | 66 | 0.0% | 0.00% | – |
Q1 2020 | $1,000 | 0.0% | 66 | 0.0% | 0.00% | – |
Q4 2019 | $1,000 | 0.0% | 66 | 0.0% | 0.00% | – |
Q3 2019 | $1,000 | 0.0% | 66 | 0.0% | 0.00% | – |
Q2 2019 | $1,000 | – | 66 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |